Keyphrases
Heparin
100%
Prospective Randomized Trial
100%
Removal Device
100%
Protamine
83%
Cardiopulmonary Bypass
50%
Activated Clotting Time
50%
No Significant Difference
33%
Heparin Concentration
33%
Adverse Reactions
16%
Life-threatening
16%
Between-group
16%
Free Hemoglobin
16%
Platelet Count
16%
Fibrinogen
16%
Activated Partial Thromboplastin Time (aPTT)
16%
Thromboelastogram
16%
Systemic Heparinization
16%
Protamine Sulfate
16%
Swine Model
16%
Tissue Histology
16%
Heparin Reversal
16%
Antithrombin III (ATIII)
16%
Nursing and Health Professions
Heparin
100%
Device Removal
100%
Efficacy
100%
Protamine
55%
Cardiopulmonary Bypass
33%
Blood Clotting Time
33%
Adverse Event
11%
Platelet Count
11%
Activated Partial Thromboplastin Time
11%
Thromboelastography
11%
Heparinization
11%
Antithrombin III
11%
Fibrinogen
11%
Complement Component C3a
11%
Protamine Sulfate
11%
Medicine and Dentistry
Heparin
100%
Device Removal
100%
Protamine
55%
Cardiopulmonary Bypass
33%
Activated Clotting Time
33%
Adverse Event
11%
Platelet
11%
Fibrinogen
11%
Partial Thromboplastin Time
11%
Heparinization
11%
Protamine Sulfate
11%
Thromboelastography
11%
Complement Component C3a
11%
Antithrombin III
11%
Pharmacology, Toxicology and Pharmaceutical Science
Heparin
100%
Protamine
55%
Clotting Time
33%
Adverse Event
11%
Thromboplastin
11%
Fibrinogen
11%
Porcine Model
11%
Protamine Sulfate
11%
Antithrombin III
11%
Complement Component C3a
11%
Veterinary Science and Veterinary Medicine
Heparin
100%
Blood Plasma
11%
Platelet
11%
Thrombin
11%
Fibrinogen
11%